Navigation Links
Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results
Date:7/19/2009

p>

Results of a second Phase 3 trial of Benlysta(TM), known as BLISS-76, are expected later this year. That trial has enrolled 826 participants at 133 clinical sites in 19 countries, primarily in North America and Europe.

BLISS-52 and BLISS-76 are the largest clinical trials ever conducted in people with lupus.

First of its kind

"Benlysta(TM) is the first 'targeted biological agent' developed specifically for systemic lupus that has the potential to obtain FDA approval. . .with the positive results of this 52-week trial and pending the results of the 76-week trial," said Tammy O. Utset, MD, MPH, an associate professor of medicine at the University of Chicago.

"HGS took a very ambitious development approach--huge international concurrent trials which represent a large investment in systemic lupus therapy," Utset added.

"The lupus community commends HGS and GlaxoSmithKline for their commitment and perseverance in finally bringing this potential new lupus treatment to trial," said Dowd. "And we thank the hundreds of people with lupus who enrolled and took part in this important trial. Participation like theirs is critical to finding answers to this illness."

The LRI builds the research pipeline and assists in recruiting patients to participate in trials to bring safe and effective treatments to market for people with lupus.

To learn more about lupus clinical trials, log on to www.LupusTrials.org.

About Lupus

Systemic lupus erythematosus (SLE) or lupus, one of the nation's least recognized major diseases, is a chronic and potentially fatal autoimmune disorder that affects more than 1.5 million Americans, primarily women in their childbearing years. In lupus, the body's immune system
'/>"/>

SOURCE Lupus Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
2. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
3. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
6. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
10. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
11. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... MADRID , October 30, 2014 ... build tolerance for cow milk   Cow milk protein allergy ... infants and early childhood. Until now, it has been ... Recently, it has been shown that it is possible ... in a significant number of children during the first ...
(Date:10/30/2014)... , Oct. 29, 2014 The ... basis of test type, technology, product, and geography. ... the highest growth rate in the newborn screening ... high growth is attributed to various nations opting ... a fundamental instrument used for expanded newborn screening. ...
(Date:10/30/2014)... 2014 Hospital stretchers are apparatus used ... another, inside or outside of medical infrastructure premises. ... also used for several specialized functions such as ... platforms. The hospital stretchers market report ... market potential of hospital stretchers globally. The hospital ...
Breaking Medicine Technology:Experts Present Latest Research at Allergy Day 2Experts Present Latest Research at Allergy Day 3NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 2NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 3Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3
... MORRISVILLE, N.C., Aug. 31 TeleTracking Technologies, ... includes temperature measurement that is NIST traceable and ... temperature sensors certified to be waterproof and dustproof ... even in potentially damaging environmental conditions to extend ...
... 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT... -- DALLAS, Texas, August 31, 2010 ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
Cached Medicine Technology:NIST-traceable Temperature Tracking Provides Visual Alert RadarFind Sensor Now Waterproof Certified 2NIST-traceable Temperature Tracking Provides Visual Alert RadarFind Sensor Now Waterproof Certified 3The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 2The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 3The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 4The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 5The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 6The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 7The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 8The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 9
(Date:10/30/2014)... 30, 2014 Victory Healthcare, a ... 2014 third quarter infection rates and patient satisfaction ... rates of only two percent or less, and ... exceeding 98 percent. , “We are delighted with ... rising satisfaction scores,” said Robert Helms, chairman and ...
(Date:10/30/2014)... Oct. 29, 2014 (HealthDay News) -- Scientists who used ... laboratory say their breakthrough could provide a new way ... stomach diseases. The team used human pluripotent stem ... in the body -- to grow the functional miniature ... bacteria, a major cause of ulcers and stomach cancer. ...
(Date:10/30/2014)... Many U.S. colleges have indoor tanning salons on ... risk for skin cancer, researchers report. Tanning ... so colleges should adopt tanning-free policies, to help ... health efforts are needed to raise university administration ... indoor tanning poses to young adults in order ...
(Date:10/30/2014)... (HealthDay News) -- A new vaccine that could help ... approved by the U.S. Food and Drug Administration on ... the ages of 10 and 25 from invasive meningococcal ... bacteria. The bacteria can infect the bloodstream (sepsis) ... brain. It is a leading cause of bacterial meningitis, ...
(Date:10/29/2014)... The development of minimally and even non-invasive technologies is ... for instance, to carry out a range of operative ... scalpel, leaving only tiny scars as a result. Similar ... active agents to patients – instead of using injections ... be possible to supply them via a plaster which ...
Breaking Medicine News(10 mins):Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:FDA Approves New Vaccine to Protect Against Meningitis 2Health News:Gentle caffeine boost for premature babies 2
... SOMERSET, N.J., Jan. 9 TeamStaff, Inc.,(Nasdaq: ... administrative,staffing services, today announced that on January 4, ... Nasdaq Stock Market ("Nasdaq"),indicating that TeamStaff,s common stock ... The Nasdaq,s determination was based on its July ...
... combat mortality , , WEDNESDAY, Jan. 9 (HealthDay News) -- ... question the conventional wisdom of treating with corticosteroids, intensive ... called pentastarch. , The first study compared the ... septic shock and found no improvement in survival rates. ...
... made that New Years resolution to exercise more, but already youre ... You know all the benefits of a healthy lifestyle: In addition ... been linked to reduced depressive symptoms and reduced risk for heart ... TV instead of going for a short jog is just too ...
... ROUGE, La., Jan. 9 The 11th annual ... Forum,entitled "Eliminating Disparities and Improving Access to,Relationship-Centered Care," ... Inn,Select, 4728 Constitution Avenue, Baton Rouge, La., from ... is redesigning patient-care delivery and improving access to,its ...
... Group Inc.,(Nasdaq: GSIG ), a leading manufacturer of ... be presenting at both the,Needham & Company 10th Annual ... the Fifth Annual Sidoti & Company Emerging Growth Conference ... Bowen, Chief Financial Officer, will be speaking at both,events., ...
... Americans increasingly seek a quick fix to physical and ... of a debate about the potential benefits and drawbacks ... panel discussion entitled, The Uses of Medications in Psychoanalysis: ... by internationally renowned psychoanalyst Glen O. Gabbard, M.D., at ...
Cached Medicine News:Health News:TeamStaff Receives Nasdaq Determination Letter 2Health News:TeamStaff Receives Nasdaq Determination Letter 3Health News:Standard Septic Shock Treatments Ineffective 2Health News:Standard Septic Shock Treatments Ineffective 3Health News:Standard Septic Shock Treatments Ineffective 4Health News:Exercising judgment: The psychology of fitness 2Health News:Exercising judgment: The psychology of fitness 3Health News:Exercising judgment: The psychology of fitness 4Health News:Exercising judgment: The psychology of fitness 5Health News:Exercising judgment: The psychology of fitness 6Health News:Exercising judgment: The psychology of fitness 7Health News:Exercising judgment: The psychology of fitness 8Health News:Exercising judgment: The psychology of fitness 9Health News:Exercising judgment: The psychology of fitness 10Health News:LSU Forum Examines Health-Care Disparities and Access to Care 2Health News:GSI to Present at Upcoming Investor Growth Conferences 2Health News:Uses of medications in psychoanalysis 2
Designed to give maximum drying area while taking up minimal bench space....
Used to remove wrinkles from sections and for reorientating embedded tissue....
Compact instrument that quickly dries racks of slides using warm air....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: